US Patent Issued to Psomagen on March 17 for "Epitope-based approach for allergy treatments and inhibitors for Crohn's disease" (California Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,576,123, issued on March 17, was assigned to Psomagen Inc. (Rockville, Md.).

"Epitope-based approach for allergy treatments and inhibitors for Crohn's disease" was invented by Zachary Apte (San Francisco), Jessica Richman (San Francisco), Daniel Almonacid (San Francisco), Mario Saavedra (San Francisco) and Ingrid Araya (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to pharmaceutical compounds and compositions and methods for treating an allergy and Crohn's disease. Methods for treating an allergy can include (a) predicting potential epitopes based proteomes of microbiome and that of an allergen, (b) filteri...